共 50 条
- [41] Cost-effectiveness between pazopanib and sunitinib for metastatic renal cancer from the perspective of the Brazilian Unified National Health System CADERNOS DE SAUDE PUBLICA, 2019, 35 (08):
- [46] Effectiveness of Standard-Dose vs. Low-Dose Alteplase for Acute Ischemic Stroke Within 3-4.5 h FRONTIERS IN NEUROLOGY, 2022, 13
- [48] Does Renal Dysfunction Modify the Effect of Intravenous Thrombolysis for Acute Ischemic Stroke within 4.5 Hours of Onset? A Multicenter Observational Study JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (03): : 673 - 679
- [49] Results of Intravenous Thrombolysis Within 4.5 to 6 Hours and Updated Results Within 3 to 4.5 Hours of Onset of Acute Ischemic Stroke Recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR) An Observational Study JAMA NEUROLOGY, 2013, 70 (07) : 837 - 844
- [50] Analyzing Cost-Effectiveness of Allocating Neurointerventionist for Drive and Retrieve System for Patients with Acute Ischemic Stroke JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (08):